Daily Caffeinated Coffee After Cardioversion Cuts Atrial Fibrillation Recurrence: Results from the DECAF Randomized Trial
Posted inCardiology news

Daily Caffeinated Coffee After Cardioversion Cuts Atrial Fibrillation Recurrence: Results from the DECAF Randomized Trial

The DECAF randomized trial found that encouraging caffeinated coffee consumption (≈1 cup/day) after successful cardioversion reduced clinically detected AF/flutter recurrence over 6 months versus caffeine abstinence (47% vs 64%; HR 0.61). Results challenge routine caffeine restriction in AF patients but require confirmation and contextualization.
Low-Dose Caffeine Boosts Cognitive Function but Not Physical Performance in Fatigued Taekwondo Athletes: Insights from a Randomized Crossover Trial
Posted inFamily Medicine & Nutrition Neurology Specialties

Low-Dose Caffeine Boosts Cognitive Function but Not Physical Performance in Fatigued Taekwondo Athletes: Insights from a Randomized Crossover Trial

A 200 mg caffeine dose enhances cognitive processing by reducing brain fatigue markers without improving physical performance in fatigued Taekwondo athletes. The findings underscore caffeine's selective benefit on mental function over physical agility post-fatigue.